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A esperança de vida dos doentes com fibrose quística 
(FQ) tem vindo a aumentar, sendo mais frequente a 
identificação de osteoporose. A patogénese de uma 
baixa densidade mineral óssea (DMO) na FQ parece 
ser multifactorial e o objectivo deste trabalho foi ava-
liar a prevalência de baixa DMO num grupo de doen-
tes com FQ e a sua correlação com outros parâmetros 
avaliados.
O estudo incluiu 22 doentes com FQ com idades 
compreendidas entre os 14 e os 45 anos (média 26,3), 
dois dos quais transplantados pulmonares. A DMO 
foi avaliada por densitometria óssea ao nível da colu-
na lombar e do colo do fémur. Estes dados foram cor-
relacionados com os valores séricos de 25-hydroxivi-
tamina D, o IMC e o volume expiratório máximo 
forçado no primeiro segundo (VEM).
Abstract
Patients with cystic fibrosis (CF) have an increasing 
life span and osteoporosis has become a more recog-
nised problem in these patients. The pathogenesis of 
low bone mineral density (BMD) in CF seems to be 
multifactorial and the aim of this study was to assess 
the prevalence of low BMD in a group of CF outpa-
tients and to relate the findings with the variables 
studied.
The study included 22 patients aged between 14 and 
45 years (mean age 26.3). Two of the subjects were 
lung transplant patients. BMD was assessed by dual-
energy X-ray absorptiometry (DEXA) at the lumbar 
spine (LS) and femoral neck (FN). This data was cor-
related with serum 25-hydroxy vitamin D (25-OHD) 
levels, BMI and the forced expiratory volume in one 
second (FEV1). 
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Os valores da DMO (Z-score  e T-score) variaram entre 
0,6 e -6 e entre 0,5 e -6,7, respectivamente, a nível da 
coluna lombar e entre 0,6 e -3,9 e  0,6 e -4,1 a nível 
do colo do fémur. A média das concentrações séricas 
de 25-(OH)D (12,57 ng/ml) encontrava-se no limite 
inferior da normalidade (10-60 ng/ml). Em média os 
doentes não apresentavam malnutrição mas os valores 
de IMC variam entre 15,2 e 33,7 kg/m2. Relativa-
mente à função pulmonar, 64% dos doentes apresen-
tavam VEM inferior a 80% e, destes, quatro tinham 
valores inferiores a 40%. Foi encontrada uma correla-
ção positiva entre valores baixos de DMO e VEM, 
assim como entre valores de DMO e 25-OHD. Não 
houve correlação linear entre IMC e DMO.
Rev Port Pneumol 2008; XIV (5): 625-634
Palavras-chave: Fibrose quística, densidade mineral 
óssea, vitamina D.
BMD (Z-score and T-score) ranged from 0.6 to -6 
and from 0.5 to -6.7 at LS; at FN the scores ranged 
from 0.6 to -3.9 and from 0.6 to -4.1. The mean se-
rum 25-OHD concentration (12,57 ng/ml) was at 
the low end of the normal range (10-60 ng/ml). On 
average patients did not present with malnutrition, 
however BMI ranged from 15.2 to 33.7 kg/m2. Lung 
function status was assessed by FEV1; 64% of patients 
had FEV1 below 80% and within this group four pa-
tients had a FEV1 under 40%.  
There was a positive correlation between low BMD 
and 25-OHD concentrations and also between BMD 
and FEV1. There was no linear correlation between 
BMD and BMI.
Rev Port Pneumol 2008; XIV (5): 625-634
Key-words: Cystic fibrosis, bone mineral density, vi-
tamin D.
Introduction
Low bone mineral density was first recog-
nised to occur in patients with Cystic Fibro-
sis (CF) in the late 1970s¹ and much re-
search has been performed investigating the 
prevalence, natural history, prevention and 
treatment of CF-related low bone mineral 
density (BMD).
The aetiology of low BMD in CF patients is 
likely to be multifactorial and includes mal-
absorption of vitamins and minerals, hor-
monal deficiencies, systemic glucocorticoid 
use, inflammatory cytokines in moderate/se-
vere lung disease, nutritional status, decreased 
physical activity and CF-related diabetes².
Prevention and recognition of low BMD 
is important as the clinical consequence 
of fragility fracture can impact adversely 
on the health of the individuals. Vertebral 
and rib fractures are particularly detri-
mental, as sputum clearance can be com-
promised, resulting in pulmonary exacer-
bations. Furthermore, it is becoming 
increasingly common for patients to be 
refused lung transplantation if they have 
low BMD.
The purpose of this study was to assess 
bone mineral density in a cystic fibrosis 
outpatient clinic population and to inves-
tigate the relationship between BMD and 
forced expiratory volume in one second 
(FEV1), body mass index (BMI) and 
25-hidroxivitamin D (25-OHD) serum 
levels.
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Material and methods
This was a prospective study carried out 
over a six month period and 22 CF patients 
from the outpatient clinic were included. A 
diagnosis of CF was made by sweat test and 
genotyping. The two patients who had re-
ceived a lung transplant were also included. 
All the subjects underwent Dual-Energy 
X-ray Absorptiometry (DEXA) studying 
and BMI, FEV1 and 25-OHD measure-
ments.
Additional data was obtained from the out-
patient clinic files which are regularly up-
dated.
BMD was measured using DEXA testing at 
the Nuclear Medicine Department of Coim-
bra University Hospital. All tests were per-
formed with the same unit. Bone density 
was measured at the lumbar spine (LS) 
[L1-L4] as well as the femoral neck (FN) and 
was expressed as the number of grams of 
bone mineral per square centimetre of bone. 
The data were also expressed as a Z-score 
and a T-score. A T-score is the number of 
standard deviations (SDs) below the mean 
score for young adult control subjects, while 
the Z-scores reflects the number of SDs be-
low the mean of age-matched control sub-
jects. Osteopaenia is defined according to 
the World Health Organization as being 
present if the T-score is between -1.0 and 
-2.5 and osteoporosis is defined as a T-score 
that is < -2.5 3. Due to uncertainties within 
the CF population, the BMD values recom-
mended should be expressed as Z-scores in 
premenopausal females and males aged un-
der 50 years, and as T-scores thereafter1. In 
this study the authors have assessed BMD 
in terms of score values as the designation 
“osteoporosis” should be confined to those 
with a history of fragility fracture and “low 
BMD” applied to children or adults with a 
BMD score below -21.
For anthropomorphic evaluation the body 
mass index (BMI) was used including the 
cut-off points for each category as stated by 
World Health Organization data.
Lung function was assessed by spirometry 
which is carried out on average every two 
months. FEV1, expressed as a percentage of 
normal predicted values, was used consider-
ing the best value obtained during the six-
month period of the study. 
Blood was drawn for biochemistry measure-
ments 25-OHD which is the most accurate 
measure of the amount of vitamin D in the 
body. This parameter is assessed routinely in 
annual review of each patient.
Correlation analysis was the main method of 
statistical analysis used. The covariance be-
tween BMD and other variables measured 
for the patient population was obtained 
 using the Pearson product-moment correla-
tion, where high correlation, according to 
the Cohen effect size classification (over 0.5 
for a small population within a biomedical 
environment), was obtained for BMD va-
rian ce with BMD, FEV1 and Vitamin D. 
Where the coefficient was high, the Pearson 
asymmetry coefficient was calculated to ob-
tain the skewness of the deviation.  
Where the correlation analysis yielded a low 
to medium, according to Cohen coefficient, 
i.e. less than 0.3, Bayesian credible intervals 
were applied, such as when comparing Vita-
min D to BMI.
Results
Of the 22 patients included in the study, 15 
were female and 7 male. Mean age was 26.3 
years [14-45].
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The characteristics of the subjects are shown 
in Table I.
BMD (Z-score and T-score) ranged from 
0.6 to -6 and from 0.5 to -6,7 at LS; at FN 
the scores ranged from 0.6 to -3.9 and from 
0.6 to -4,1. (Fig. 1 and Fig. 2)
Overall 14 of 22 patients (64%) were 
found to have reduced BMD at any site. 
Nine of those subjects (64%) had a Z score 
between -1 and -2, while five (23%) sub-
jects had very low Z score (<-2) as shown 
in Fig. 3. 
The Z and T score distributions show that 
average values are below normal range.
As shown in Fig. 1, the Z-score distribution 
is on average below normal range and a mi-
nority of patients have normal BMD.
Average BMI was 21.97 kg/m2 and although 
two patients had low body mass (below 16 
kg/m2) most patients had adequate nutri-
tional status (Fig. 4).
Lung function assessment showed that 64% 
of patients had FEV1 (percent predicted) be-
low 80% and within this group four patients 
had a FEV1 under 40% (Fig. 5).
Table I – Patient characteristics
Age, yrs [min-max] [14 - 46]
Female gender, % 68% (n=15)
BMI, kg/m2 [min-max] [15.2 - 33.7]
FEV1, % [min-max] [17.9 - 98]
25-OHD, ng/ml [min-max] [3.5 - 27]
Pancreatic insuffi ciency, % 68% (n=15)
Bacterial colonisation, % 100% (n=22)
Diabetes, % 23% (n=5)
Receiving oral steroids, % 18% (n=3)
Receiving biphosphonates, % 18% (n=3)
Lung transplant pts, % 9% (n=2)
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Fig 1 – Z score distribution
Z-Lumbar Z-Femur 
  Mean - 1.54 - 1.31
  Max  0.6   0.6 
  Mín  -6  -3.9
Z-Lumbar Z-Femur
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The mean serum 25-OHD concentration 
(12.57ng/ml) was at the low end of the normal 
range (10 to 60 ng/ml)5; 4 of 22 patients (18%) 
had frankly low (< 10 ng/ml) levels. (Fig. 6)
The dietary recall revealed adequate intake of 
calcium, phosphorus and calories according 
to the nutritional recommendations laid out 
in the European Cystic fibrosis Consensus6.
When analysed individually FEV1 was posi-
tively associated with BMD at the LS and 
the FN as demonstrated by the Correlation 
Coefficient (64%) illustrated in Fig. 7. Like-
wise a positive correlation (CC 60%) was 
found between 25-OHD and BMD (Fig. 
8). No significant correlation was found be-
tween BMI and low BMD (CC 12%) as 
observed in Fig. 9.
T-Lumbar T-Femur 
 Mean   -1.618 -1.39 
 Max 0.6 0.6 
 Min -6.7 -4.1
Fig. 2 – T score distribution
Fig. 3 – BMD assessment
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Fig. 4 – BMI distribution
Mean  21.97 
Max 33.7 
Min 15.2
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Fig. 5 – FEV1 distribution
Mean  66.05 % 
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Discussion
CF patients both before and after lung 
transplantation have a complex metabolic 
disease that is not typical of vitamin D defi-
ciency: osteomalacia. Although bone densi-
ty is generally reduced in CF adults and 
there is evidence relating this to vitamin D 
insufficiency, most studies suggest that CF-
related bone disease has a more multifacto-
rial aetiology with additional factors such as 
disease severity, general malnutrition and 
pancreatic disease7.
Several techniques are available to assess 
bone mass, including dual energy x-ray ab-
sorptiometry (DEXA) which is most com-
monly used because it is non-invasive, high-
ly reproducible and delivers an extremely 
low dose of radiation¹. Furthermore, DEXA 
testing is considered gold standard as it as-
sesses both trabecular and cortical bone.
The overall BMI in our study population 
was similar to a range of 18 to 21 kg/m2 
seen in other studies5,6.
This group of patients had an adequate nu-
tritional status and overall no significant 
correlation with BMD was found. However, 
on an individual analysis, the patient with 
lower BMI (15.2 kg/m2) also had the most 
severe bone loss (Z-score -6 and -3.9 at the 
LS and FN respectively). 
Pulmonary damage due to tissue inflamma-
tion post colonisation leads to increased 
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Fig. 6 – Distribution of 25–OHD measurements
25-OHD (Ng/ml)
Mean  12.57 ng/ml
Max 27 ng/ml
Min 3.5 ng/ml
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Fig. 7 – BMD / FEV1 correlation
Correlation coeffi cient 0.64 



















Fig. 8 – BMD / Vitamin D correlation
Correlation coeffi cient 0.6
Asymmetry coeffi cient 0.8
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cyto kines which precedes lung function impair-
ment. These cytokines stimulate bone resorp-
tion which may be a contributing factor in the 
association between disease severity and BMD. 
Accordingly, FEV1 was found to be positively 
correlated with low bone density.
Pancreatic-insufficiency is common in CF 
patients and this causes malabsorption of 
fat soluble vitamins (D,E,A and K). Vita-
min D deficiency can lead to osteomalacia 
and secondary hyperparathyroidism in-
creases bone turnover which causes osteo-
porosis. Most authors quote optimum 
25-OHD serum levels as being in the 20-60 
ng/ml (50-150 nmol/ L) range1,4 and this 
wide range is due to differences in latitude 
and season.
The results found in this study suggest that 
management should be optimised assuring 
that patients are absorbing adequate 
amounts of vitamin D. Interestingly five pa-
tients with no pancreatic insufficiency had 
low serum 25-OHD measurements which 
may be an aspect meriting further investiga-
tion.
It seems there is a high prevalence of low 
BMD in this adolescent and adult group of 
CF patients and more frequently affecting 
the femoral neck. Lung disease and low vi-
tamin D are factors that are positively asso-
ciated with BMD. All preventive measures 
should be undertaken to ensure bone di-
sease does not progress and management 
should be optimised whenever necessary9. 
Vitamin D levels should be checked annu-
ally and supplementation is recommended 
in all patients with low BMD. Alternative 
strategies such as UVB therapy and treat-
ment with bisphosphonates may also be 
considered.
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Fig. 9 – BMI / BMD correlation 
Correlation coeffi cient  0.12
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